Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sue Darcey

Senior Reporter

Washington, D.C.
Sue Darcey is a senior reporter covering the medical device and diagnostics industry. Her current fields of expertise and interest include monitoring medical device post market performance and safety, development of new genomic and laboratory developed tests, the influence of industry lobbying and campaign contributions over Senators’ and Representatives’ voting practices and lawmaking on devices, and FDA approvals of diagnostics for emerging diseases, including tests for Ebola and Zika viruses. A Washington, D.C.-based trade journalist with over 30 years’ experience covering Capitol Hill and regulatory agencies including FDA, CMS and the Environmental Protection Agency, Sue is constantly on the look-out for any problems or safety issues connected to device use, ways that firms resolve those issues, and any new regulations that arise from the challenges. 
Advertisement
Set Alert for Articles By Sue Darcey

Latest From Sue Darcey

Device Week, 17 May 2019 – Gottlieb Talks Reimbursement; DeLauro Breathes New Life Into Medical Device Safety Act

In this week's Medtech Insight podcast, Danny Al-Faruque discusses a recent speech by former FDA head Scott Gottlieb at the National Press Club in Washington, DC, that focused on product reimbursement issues. And Sue Darcey talks about a new push by US Rep. Rosa DeLauro to remove PMA-product liability suit protections for devices, with her reintroduction of the Medical Device Safety Act.

Device Week Regulation

Olympus, Pentax Working On Responses To Sen. Murray Duodenoscope Contamination Concerns

Two duodenoscope manufacturers – Olympus and Pentax – this week joined Fujifilm in saying they are aware of Senate HELP Committee ranking member Patty Murray’s concerns about recently released duodenoscope contamination levels and are working to complete postmarket surveillance studies of their devices, as required by the US FDA.

Legislation Safety

US Rep. DeLauro Reintroduces Device Safety Bill To Remove PMA Product Liability Suit Protections

A US House representative and two co-sponsors have reintroduced the Medical Device Safety Act, which would remove the defense against state product liability suits for premarket-approved devices from the Federal Food, Drug, and Cosmetic Act (FDCA).

Legislation Legal Issues

'Medicare For All' Bills Prompt Warning From Former US FDA Commissioner Gottlieb

In an address to the National Press Club on 10 May, former FDA Commissioner Scott Gottlieb pointed to some of the challenges that CMS would face in supplying coverage for new technology, should a "Medicare for All" bill be adopted by Congress and signed by the president. Medtech Insight analyzed provisions that could impact industry in some of the proposed bills, in a comparative chart.

Legislation Reimbursement

Sen. Murray Prods Duodenoscope-Makers On Continued Contamination Issues

Sen. Patty Murray sent a letter this week to the three sole US duodenoscope-makers – Olympus, Fujifilm and Pentax – asking the firms to bring the contamination rates on their scopes down to between 0% and 1%. Murray's letter pointed to recent “troubling findings” from the FDA on rates of contamination from high-concern organisms.

Regulation Post Market Regulation & Studies

US House Would Boost NIH Spending By $2Bn, Support Precision Medicine, BRAIN Initiative, Cybersecurity Funds

The US National Institutes of Health would get a 5% raise of $2bn under a 2020 budget increase to $41.1bn, spending that would go to boost precision medicine research, the BRAIN Initiative, Cancer Moonshot, cybersecurity and other important programs.

Legislation Financing
See All
Advertisement
UsernamePublicRestriction

Register